BEGHE', Bianca
 Distribuzione geografica
Continente #
NA - Nord America 22.028
AS - Asia 8.144
EU - Europa 7.820
SA - Sud America 1.211
Continente sconosciuto - Info sul continente non disponibili 273
AF - Africa 198
OC - Oceania 60
Totale 39.734
Nazione #
US - Stati Uniti d'America 21.582
SG - Singapore 2.492
GB - Regno Unito 2.384
IT - Italia 2.219
CN - Cina 2.012
HK - Hong Kong 1.053
BR - Brasile 917
VN - Vietnam 802
SE - Svezia 533
DE - Germania 519
FI - Finlandia 462
BD - Bangladesh 414
UA - Ucraina 357
RU - Federazione Russa 341
FR - Francia 315
KR - Corea 248
TR - Turchia 223
ID - Indonesia 217
CA - Canada 206
IN - India 158
BG - Bulgaria 152
AR - Argentina 99
NL - Olanda 90
MX - Messico 82
IQ - Iraq 70
ZA - Sudafrica 67
CO - Colombia 64
PK - Pakistan 61
ES - Italia 60
AU - Australia 54
JP - Giappone 47
IE - Irlanda 45
RO - Romania 44
AT - Austria 41
PL - Polonia 39
AE - Emirati Arabi Uniti 37
MY - Malesia 37
VE - Venezuela 32
CL - Cile 31
LT - Lituania 31
BE - Belgio 29
IL - Israele 29
EC - Ecuador 28
IR - Iran 28
CH - Svizzera 26
CR - Costa Rica 25
PH - Filippine 22
SA - Arabia Saudita 22
JM - Giamaica 21
TH - Thailandia 20
NI - Nicaragua 18
NP - Nepal 17
GT - Guatemala 16
JO - Giordania 16
PY - Paraguay 16
RS - Serbia 16
UZ - Uzbekistan 16
KE - Kenya 15
MA - Marocco 15
PT - Portogallo 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
EG - Egitto 13
SY - Repubblica araba siriana 13
TN - Tunisia 13
HN - Honduras 12
PR - Porto Rico 12
SC - Seychelles 12
DO - Repubblica Dominicana 11
TT - Trinidad e Tobago 11
AL - Albania 10
DZ - Algeria 10
EE - Estonia 10
KZ - Kazakistan 10
SV - El Salvador 10
UY - Uruguay 9
AZ - Azerbaigian 8
BF - Burkina Faso 8
ET - Etiopia 8
MD - Moldavia 8
NO - Norvegia 8
PE - Perù 8
SI - Slovenia 8
BH - Bahrain 7
BO - Bolivia 7
GP - Guadalupe 7
HU - Ungheria 7
LB - Libano 7
OM - Oman 7
NG - Nigeria 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
CW - ???statistics.table.value.countryCode.CW??? 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
Totale 39.385
Città #
Ashburn 2.530
Fairfield 1.600
Southend 1.573
Santa Clara 1.527
Singapore 1.474
Hong Kong 1.032
San Jose 1.006
Woodbridge 980
Chandler 931
Houston 844
Hefei 674
Council Bluffs 664
Jacksonville 664
Chicago 641
Seattle 582
Wilmington 567
Cambridge 513
Dearborn 504
Los Angeles 462
London 422
Ann Arbor 361
Beijing 352
Helsinki 337
New York 299
Salt Lake City 283
Modena 248
Milan 243
Nyköping 240
Ho Chi Minh City 235
Hanoi 225
Seoul 222
The Dalles 214
Dallas 198
San Diego 193
Princeton 164
Tampa 156
Rome 154
Sofia 146
Elk Grove Village 133
São Paulo 129
Buffalo 118
Eugene 116
Lauterbourg 113
Columbus 96
Izmir 96
Jakarta 94
Moscow 83
Naples 82
Phoenix 76
Redwood City 75
Boardman 74
Des Moines 73
Shanghai 68
Lancaster 67
Frankfurt am Main 66
Sterling 60
Atlanta 55
Toronto 51
Miami 50
Bologna 47
Orem 45
Da Nang 43
Detroit 39
Nuremberg 38
Dublin 37
Kansas City 37
Tokyo 36
Brooklyn 35
Falls Church 35
North Bergen 32
Bogotá 30
Grafing 29
Montreal 29
Verona 29
Munich 28
San Francisco 28
Charlotte 27
Florence 27
Mexico City 27
Redondo Beach 27
Warsaw 27
Ankara 26
Haiphong 26
Kent 26
Norwalk 26
Rio de Janeiro 26
Dulles 25
Baghdad 24
Bari 24
Belo Horizonte 24
Chennai 24
Miano 24
Palermo 24
Johannesburg 23
San José 22
Genoa 21
Nanjing 21
Philadelphia 21
Vienna 21
Turin 20
Totale 26.415
Nome #
The genetic basis of atopic asthma. 887
Asma bronchiale 685
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 533
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 525
Acute severe asthma: management and treatment. 426
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 416
Chronic respiratory abnormalities in the multi-morbid frail elderly 412
Roflumilast:un nuovo farmaco per il trattamento della BPCO 411
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 400
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 397
Airway inflammation in childhood asthma 391
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 386
Complex chronic co-morbidities of COPD 385
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis 377
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections 376
La broncopneumopatia cronica ostruttiva nell'anziano 372
Physiologic consequences of long term inflammation 367
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. 366
Comparison of two methods of processing induced sputum: selected versus entire sputum. 362
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 353
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 352
Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). 348
Treatment of chronic obstructive pulmonary disease and its comorbidities 346
La genetica dell’asma bronchiale. 345
Update in Chronic Obstructive Pulmonary Disease 2005 345
Inhaled Corticosteroids in COPD: Pros and Cons. 344
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 343
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 342
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 335
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 335
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 332
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 332
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 331
Update in chronic obstructive pulmonary disease 2006 329
Basi strutturali della BPCO. 328
Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. 326
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 324
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 323
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 318
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma 316
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. 315
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 315
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 311
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. 309
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 305
Polymorphisms in the interleukin-4 and interleukin-4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population 302
[Pathology of chronic obstructive pulmonary disease] 302
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. 300
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 294
Leukotriene B4 receptor locus gene characterisation and association studies in asthma 291
Role for CXCR6 and its Ligand CXCL16 in the Pathogenesis of T-cell Alveolitis in Sarcoidosis 291
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 285
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 283
Alveolar and bronchiolar inflammation in COPD 281
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 281
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma 281
Copd, pulmonary fibrosis and ilas in aging smokers: The paradox of striking different responses to the major risk factors 281
Significant chronic airway abnormalities in never-smoking HIV-infected patients 280
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 279
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 278
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 276
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 273
Eosinophilia in asthma: the easy way is not always the best 270
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 262
La NIV nel paziente con insufficienza respiratoria cronica, la gestione domiciliare - Competenza specialistica nelle patologie pneumologiche pure 261
The multiple components of COPD 256
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 254
Triple therapy for symptomatic patients with COPD 251
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 250
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 249
Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. 247
What is the origin of dyspnoea in smokers without airway disease ? 246
Genetic influences on Asthma Severity. 242
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 242
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 239
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 239
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. 237
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials 235
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. 227
Pathology of COPD and asthma 224
Identifying and Treating COPD in Cardiac Patients 218
Trattamento farmacologico dell’asma bronchiale 216
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 216
Asthma 216
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. 216
Reply: look at the moon, not just at the finger indicating the moon 213
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. 212
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema 210
Update in Asthma 2016 208
Cardiac Diseases and respiratory consequences 208
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 206
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation 203
Blood eosinophils for the management of COPD patients? 202
Malattie respiratorie ostruttive. Bronchiectasie 199
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 199
Genetic risk factors in idiopathic and non-idiopathic interstitial lung disease: similarities and differences. 198
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 197
Chronic cough in adults 197
COPD in the elderly is almost invariably associated with one or more chronic comorbidities 196
Trattamento farmacologico dell’asma bronchiale. 195
Totale 30.490
Categoria #
all - tutte 170.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.053 0 0 0 0 95 132 169 157 341 262 562 335
2022/20232.487 256 256 133 224 288 357 83 276 345 64 107 98
2023/20242.004 83 140 115 265 356 207 130 215 87 92 117 197
2024/20256.247 227 176 100 410 1.111 940 290 268 717 346 681 981
2025/202612.023 634 463 881 1.607 2.465 830 1.380 487 941 910 782 643
2026/20273.938 375 818 1.049 1.384 312 0 0 0 0 0 0 0
Totale 39.734